Biohaven Price to Free Cash Flow Ratio 2016-2023 | BHVN
Historical price to free cash flow ratio values for Biohaven (BHVN) since 2016.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Biohaven Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2023-05-31 |
17.51 |
|
0.00 |
| 2023-03-31 |
13.66 |
$-6.44 |
0.00 |
| 2022-12-31 |
13.88 |
$-6.79 |
0.00 |
| 2022-09-30 |
151.17 |
$-6.64 |
0.00 |
| 2022-06-30 |
145.71 |
$0.69 |
211.05 |
| 2022-03-31 |
118.57 |
$-1.89 |
0.00 |
| 2021-12-31 |
137.81 |
$-3.73 |
0.00 |
| 2021-09-30 |
138.91 |
$3.39 |
40.95 |
| 2021-06-30 |
97.08 |
$-3.06 |
0.00 |
| 2021-03-31 |
68.35 |
$-2.61 |
0.00 |
| 2020-12-31 |
85.71 |
$-2.00 |
0.00 |
| 2020-09-30 |
65.01 |
$-10.78 |
0.00 |
| 2020-06-30 |
73.11 |
$-8.87 |
0.00 |
| 2020-03-31 |
34.03 |
$-9.50 |
0.00 |
| 2019-12-31 |
54.44 |
$-7.86 |
0.00 |
| 2019-09-30 |
41.72 |
$-6.34 |
0.00 |
| 2019-06-30 |
43.79 |
$-6.75 |
0.00 |
| 2019-03-31 |
51.47 |
$-3.99 |
0.00 |
| 2018-12-31 |
36.98 |
$-5.14 |
0.00 |
| 2018-09-30 |
37.55 |
$-6.06 |
0.00 |
| 2018-06-30 |
39.52 |
$-5.16 |
0.00 |
| 2018-03-31 |
25.76 |
$-5.65 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.111B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
